• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Unilife Corp.

Insulet asks court to force docs from Unilife in Chap 11 sale

June 22, 2017 By Fink Densford

Insulet, Unilife

A Delaware judge this week ordered formal submissions from both Unilife (NSDQ:UNIS) and Insulet (NSDQ:PODD) as the companies fought over Unilife’s Chapter 11 sale, with Insulet claiming Unilife is selectively refusing to supply appropriate information and restricting it’s ability to participate. Insulet claims that Unilife has not provided it with enough data to make an informed bid […]

Filed Under: Business/Financial News, Featured, Legal News Tagged With: Insulet, Unilife Corp.

Unilife wins approval for Chap 11 bankruptcy plans

May 5, 2017 By Fink Densford

Unilife logo

Unilife (NSDQ:UNIS) this week won approval from the US Bankruptcy Court for the District of Delaware for its chapter 11 bid and plans for a sale, despite not having completed every step in the process. In the filing, Judge Laurie Silverstein noted that so far “no trustee, examiner or official committee of creditors holding unsecured claims” has […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Wall Street Beat Tagged With: Unilife Corp.

Bankrupt Unilife asks judge for $1m in bonuses for top execs

April 26, 2017 By Sarah Faulkner

Unilife logo

Unilife (NSDQ:UNIS), which filed for Chapter 11 bankruptcy earlier this month, reportedly asked a Delaware bankruptcy court yesterday to approve a “key employee retention plan” that would provide 4 top executives with nearly $1 million in bonuses, contingent upon a successful sale of the company. Unilife added it has already approved the plan with its debtor-in-possession lender. The […]

Filed Under: Drug-Device Combinations, Featured, Legal News, Pharmaceuticals, Wall Street Beat Tagged With: Unilife Corp.

Unilife files for Chapter 11 bankruptcy

April 12, 2017 By Sarah Faulkner

Unilife logo

Unilife (NSDQ:UNIS) filed for Chapter 11 bankruptcy today, saying it hopes to support the company’s business operations with a $7 million debtor-in-possession financing facility and its remaining cash. The cash-strapped company owes more than $22 million to Sanofi, Kahle Automation, Morgan Stanley, Hikma Pharmaceuticals and MECO Inc., according to documents that Unilife filed in the U.S. Bankruptcy […]

Filed Under: Drug-Device Combinations, Featured, Wall Street Beat Tagged With: Unilife Corp.

Unilife: Ex-CEO Shortall’s shenanigans exposed ‘material weaknesses’

September 2, 2016 By Brad Perriello

Shares in Unilife (NSDQ:UNIS) are off 7% this week after the company said its investigation into former CEO Alan Shortall turned up “material weaknesses” in its bookkeeping procedures that will require it to restate some of its financials. Shortall, who left the company in March along with COO Ramin Mojdeh, was elevated to chairman in 2013. In May, […]

Filed Under: Drug-Device Combinations, Legal News, Wall Street Beat Tagged With: Personnel Moves, Unilife Corp.

Unilife & Amgen finalize $75m co-development deal

February 22, 2016 By Fink Densford

Unilife (NSDQ:UNIS) said today it finalized a $75 million collaborative deal with Amgen (NSDQ:AMGN) for injectable drug delivery systems, a deal the companies have been working out for the past month. The deal includes licensing, investment, development and supply agreements and is centered around Unilife’s prefilled customizable wearable injectors, according to an SEC filing from the York, […]

Filed Under: Business/Financial News, Drug-Device Combinations, Research & Development Tagged With: Amgen, Unilife Corp.

Unilife taps CEO Shortall for loan to forestall default

October 7, 2015 By Brad Perriello

Unilife (NSDQ:UNIS) yesterday said it tapped chairman & CEO Alan Shortall for a loan so it could avoid defaulting on its $60 million debt with OrbiMed. Wayne, Pa.-based Unilife said it borrowed $600,000 from Shortall so it could maintain the $5 million cash balance required by the OrbiMed loan and still make a payment on the loan. […]

Filed Under: Drug-Device Combinations Tagged With: Unilife Corp.

Unilife amends Novartis supply deal

September 25, 2015 By Fink Densford

Unilife (NSDQ:UNIS) said today it amended a clinical supply agreement with Novartis (NYSE:NVS) to supply it with additional batches of Unilife’s drug delivery device for use with a novel investigational drug. The agreement, originally signed in 2013 to supply them with the deliver devices for a targeted early-stage pipeline drug, was also amended to include an […]

Filed Under: Business/Financial News, Drug-Device Combinations Tagged With: Unilife Corp.

Losses widening, Unilife pares workforce by 17%

September 15, 2015 By Brad Perriello

Unilife (NSDQ:UNIS) yesterday said it plans to lay off about 50 workers, or roughly 17% of its workforce, after reporting wider losses for its fiscal 4th quarter and full-year 2015 and missing expectations on Wall Street. Saying it now has a lineup of products to cover its target markets, York, Pa.-based Unilife said it’s looking to […]

Filed Under: Drug-Device Combinations Tagged With: Unilife Corp.

Unilife signs production deal with Flextronics

November 14, 2014 By drugdelivery

Unilife signs production deal with Flextronics

Filed Under: Drug-Device Combinations Tagged With: Flextronics, Unilife Corp.

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS